upper right abdominal pain and nausea

This item was filled under [ Most Popular ]

Phase III Novartis Data Show Potential Benefit of Afinitor® Plus Sandostatin® LAR Depot in Patients with Advanced …
EAST HANOVER, N.J. , Oct. 11 /PRNewswire/ — A Novartis Pharmaceuticals Corporation (“Novartis”) Phase III study of Afinitor® (everolimus) tablets in combination with Sandostatin® LAR Depot (octreotide acetate for injectable suspension) extended median progression-free survival (PFS), or time without tumor growth, in patients with advanced carcinoid tumors compared to taking octreotide LAR …

Be Sociable, Share!
Tags: , , , , , , , , ,
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.



#